These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7959287)

  • 1. Salvage surgery for chemorefractory ovarian germ cell tumors.
    Munkarah A; Gershenson DM; Levenback C; Silva EG; Messing MJ; Morris M; Burke TW
    Gynecol Oncol; 1994 Nov; 55(2):217-23. PubMed ID: 7959287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
    Li J; Yang W; Wu X
    Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and prognostic factors in ovarian germ cell malignancies.
    Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN
    Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged survival following salvage surgery for chemorefractory ovarian immature teratoma: a case report and review of the literature.
    Rezk Y; Sheinfeld J; Chi DS
    Gynecol Oncol; 2005 Mar; 96(3):883-7. PubMed ID: 15721445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant ovarian germ cell tumor in King Chulalongkorn Memorial Hospital.
    Lertkhachonsuk R; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Tresukosol D
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S124-8. PubMed ID: 16623016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital.
    Lertkhachonsuk R; Manchana T; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Sirisabya N; Khemapech N; Tresukosol D
    J Med Assoc Thai; 2006 Feb; 89(2):138-44. PubMed ID: 16578998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparotomy for post chemotherapy residue in ovarian germ cell tumors.
    Mathew GK; Singh SS; Swaminathan RG; Tenali SG
    J Postgrad Med; 2006; 52(4):262-5. PubMed ID: 17102543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant ovarian germ cell tumors: a single-institution experience.
    Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
    Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.
    Kesler KA; Rieger KM; Hammoud ZT; Kruter LE; Perkins SM; Turrentine MW; Schneider BP; Einhorn LH; Brown JW
    Ann Thorac Surg; 2008 Feb; 85(2):371-8. PubMed ID: 18222228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients.
    Ogawa K; Toita T; Nakamura K; Uno T; Onishi H; Itami J; Shikama N; Saeki N; Yoshii Y; Murayama S
    Cancer; 2003 Jul; 98(2):369-76. PubMed ID: 12872359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?
    Zang RY; Li ZT; Tang J; Cheng X; Cai SM; Zhang ZY; Teng NN
    Cancer; 2004 Mar; 100(6):1152-61. PubMed ID: 15022281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary.
    Kumar S; Shah JP; Bryant CS; Imudia AN; Cote ML; Ali-Fehmi R; Malone JM; Morris RT
    Gynecol Oncol; 2008 Aug; 110(2):125-32. PubMed ID: 18571705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphadenectomy in the treatment of malignant ovarian germ cell tumor].
    Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):743-8. PubMed ID: 16447650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged disease-free survival by maintenance chemotherapy among patients with recurrent platinum-sensitive ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Blumenson LE
    Gynecol Oncol; 1998 Nov; 71(2):190-5. PubMed ID: 9826459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary.
    Nishio S; Ushijima K; Fukui A; Fujiyoshi N; Kawano K; Komai K; Ota S; Fujiyoshi K; Kamura T
    J Obstet Gynaecol Res; 2006 Aug; 32(4):416-21. PubMed ID: 16882268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.